WALTHAM, Mass., Aug. 21, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, announced that Lonnie Moulder, CEO, Mary Lynne Hedley, Ph.D., President and COO, and Tim Pearson, Executive Vice President and CFO of TESARO, will participate in several upcoming investor conferences during the month of September, including:
- Citi's 9th Annual Biotech Day at the Mandarin Oriental Hotel in Boston on Wednesday, September 3, 2014
- Baird's 2014 Health Care Conference at The New York Palace Hotel in New York City on Thursday, September 4, 2014 at 1:25 p.m. EDT. A live webcast will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference.
- The Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City on Tuesday, September 9, 2014.
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by acquiring, developing and commercializing safer and more effective therapeutics. For more information, visit www.tesarobio.com.
CONTACT: Investor/Media Contact: Jennifer Davis Sr. Director, Corporate Development & Investor Relations +1.781.325.1116 email@example.com